Precision BioSciences(DTIL)
搜索文档
Precision BioSciences(DTIL) - 2020 Q4 - Annual Report
2021-03-18 00:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-38841 | --- | --- | |---------------------------------------------------------------------------------------------------------------- ...
Precision BioSciences(DTIL) - 2020 Q3 - Quarterly Report
2020-11-10 20:30
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to | --- | --- | |-------------------------------------------------------------------------------------------------------------------------------------|---- ...
Precision BioSciences(DTIL) - 2020 Q2 - Quarterly Report
2020-08-13 19:03
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to | --- | --- | |-------------------------------------------------------------------------------------------------------------------------------------|--------- ...
Precision BioSciences(DTIL) - 2020 Q1 - Quarterly Report
2020-05-15 19:02
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to | --- | --- | |-------------------------------------------------------------------------------------------------------------------------------------|-------- ...
Precision BioSciences (DTIL) Presents At Barclays Global Healthcare Conference - Slideshow
2020-03-14 02:34
PRECISION BIOSCIENCES | --- | --- | --- | --- | |------------|------------------------------|-------|-------| | | | | | | | Dedicated to Improving Life. | | | | March 2020 | | | | | | Overcome cancer. | | | | | Cure genetic disease. | | | | | Feed the planet. | | | Forward Looking Statements This presentation (together with any other statements or information that we may make in connection herewith) may contain forward-looking statements. All statements other than statements of present and historical facts ...
Precision BioSciences(DTIL) - 2019 Q4 - Annual Report
2020-03-10 19:01
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-38841 | --- | --- | |---------------------------------------------------------------------------------------------------------------- ...
Precision BioSciences (DTIL) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow
2020-01-17 02:52
PRECISION IENCES | --- | --- | |----------------------------------------------------------------|-------| | | | | | | | | | | | | | Dedicated to Improving Life. | | | 38th Annual J.P. Morgan Healthcare Conference January 15, 2020 | | | Overcome cancer. | | | Cure genetic disease. | | | Feed the planet. | | Forward Looking Statements This presentation (together with any other statements or information that we may make in connection herewith) may contain forward-looking statements. All statements other than s ...
Precision BioSciences(DTIL) - 2019 Q3 - Quarterly Report
2019-11-12 20:03
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38841 Precision BioSciences, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 20-4206017 (State or other ...
Precision BioSciences(DTIL) - 2019 Q2 - Quarterly Report
2019-08-15 04:31
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38841 | --- | --- | --- | |-----------------------------------------------------------------------------------------------------|- ...
Precision BioSciences(DTIL) - 2019 Q1 - Quarterly Report
2019-04-30 04:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to | --- | --- | |----------------------------------------------------------------------------------------------------------------------------------------|----- ...